Hengrui Medicine (01276.HK) spent 12.7432 million yuan on November 20 to repurchase 209,900 shares of A shares.

Cailian Press News, Hansoh Pharmaceutical (01276.HK) announced that the company repurchased 209,900 shares of A shares on November 20, 2025, at a cost of 12,743,200 yuan, with a repurchase price per share of 60.58-60.78 yuan.